New minimally invasive treatment effective for benign prostatic obstruction

Reuters Health - 17/09/2020 - Transperineal interstitial laser ablation (TPLA) offers another effective minimally invasive treatment for men with benign prostatic obstruction, researchers in Italy report. There are a number of minimally invasive treatments for men with lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) or benign prostatic obstruction (BPO). TPLA uses laser light to cause irreversible necrosis of the cells inside an ellipsoid measuring approximately 22.5 mm in longitudinal diameter and 16 mm in transversal diameter, one-third of which is located behind the tip of the optic fiber and two-thirds of which is located in front of it. Dr. Gaetano de Rienzo and colleagues of the University of Bari describe their experience with 21 men who underwent TPLA for BPO at their center. The patients' median age was 62 years, and their median prostate volume was 40 mL. The mean operative time was 36 minutes, and there ...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 17 September, 202030 September, 2020